Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precision Components Group (PCG) was a leading manufacturer of high-precision metal components, primarily serving the medical device, aerospace, and defense industries. The company specialized in the production of complex, tight-tolerance parts for critical applications, including surgical instruments and orthopedic implants. PCG was formed as a platform company by the private equity firm Insight Equity through the consolidation of several precision manufacturing entities. In 2015, the group was acquired by NN, Inc. for approximately $375 million to expand its industrial and life sciences capabilities. Following a strategic reorganization, NN, Inc. divested its Life Sciences division, including the medical assets of the former PCG, to American Securities in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision Components Group.